Insider Transactions
| Date | Filing | Filer | Title | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Mar 19, 2004 | Form 4 |
Director, President and COO
Trans History: 421
|
Director, President and COO | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 109 | -- | 109 |
| Aug 01, 2007 | Form 4 |
Director
Trans History: 199
|
Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 108 | $78.63 | 46,145 |
| Oct 15, 2014 | Form 4 |
Director, President and COO
Trans History: 95
|
Director, President and COO | Bona fide gift | 106 | -- | 103,710 |
| Nov 16, 2004 | Form 4 |
Director, Chief Financial Officer
Trans History: 282
|
Director, Chief Financial Officer | Open market or private sale of non-derivative or derivative security | 106 | $52.16 | 231,578 |
| Feb 07, 2023 | Form 4 |
Director, Executive Chairman
Trans History: 1071
|
Director, Executive Chairman | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 105 | -- | -- |
| May 05, 2021 | Form 4 |
Director
Trans History: 36
|
Director | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 105 | -- | 7,472 |
| May 05, 2021 | Form 4 |
Director
Trans History: 36
|
Director | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 105 | -- | -- |
| May 05, 2021 | Form 4 |
Director
Trans History: 25
|
Director | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 105 | -- | 4,179 |
| May 05, 2021 | Form 4 |
Director
Trans History: 25
|
Director | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 105 | -- | -- |
| May 05, 2021 | Form 4 |
Director
Trans History: 37
|
Director | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 105 | -- | 7,258 |
Data provided by Kaleidoscope.
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.